{
    "organizations": [],
    "uuid": "ca28917b7c04cbeebe951c935598a695aa349fe1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biomerica-says-mexicos-cofepris-ap/brief-biomerica-says-mexicos-cofepris-approval-of-ez-detect-colorectal-screening-test-sec-filing-idUSFWN1QQ0I8",
    "ord_in_thread": 0,
    "title": "BRIEF-Biomerica Says ‍Mexico's Cofepris' Approval Of EZ Detect Colorectal Screening Test​ - SEC Filing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Biomerica Inc:\n* BIOMERICA SAYS ‍MEXICO’S COFEPRIS’ APPROVAL OF EZ DETECT COLORECTAL SCREENING TEST​ - SEC FILING\n* BIOMERICA SAYS APPOINTED DNA BIOPHARMA (DNA) AS EXCLUSIVE DISTRIBUTOR FOR EZ DETECT PRODUCT IN MEXICO Source text: ( bit.ly/2oSHNYl ) Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T19:41:00.000+02:00",
    "crawled": "2018-03-09T14:52:27.053+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "biomerica",
        "inc",
        "biomerica",
        "say",
        "cofepris",
        "approval",
        "ez",
        "detect",
        "colorectal",
        "screening",
        "sec",
        "filing",
        "biomerica",
        "say",
        "appointed",
        "dna",
        "biopharma",
        "dna",
        "exclusive",
        "distributor",
        "ez",
        "detect",
        "product",
        "mexico",
        "source",
        "text",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}